Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
life sciences
Pharma
Biopharma status quo likely to persist under Trump 2.0: analyst
The healthcare status quo is likely "to persist for some time" under president-elect Donald Trump, Baird analyst Mike Perrone opined Thursday.
Fraiser Kansteiner
Nov 21, 2024 1:15pm
Fierce 50 of 2024
Sep 9, 2024 5:02am
Fierce 50 spotlight: Patient Advocacy lead Paige Minemyer
Sep 6, 2023 9:30am
Fierce 50 spotlight: Breakthroughs category lead Eric Sagonowsky
Sep 5, 2023 11:50am
Fierce 50 spotlight: Social Impact category chair Andrea Park
Aug 29, 2023 11:53am
Fierce 50 spotlight: Health Equity lead Anastassia Gliadkovskaya
Aug 16, 2023 3:35pm
